Your browser doesn't support javascript.
Infection prevention strategies are highly protective in COVID-19 units while main risks to healthcare professionals come from coworkers and the community.
Gohil, Shruti K; Quan, Kathleen A; Madey, Keith M; King-Adelsohn, Suzanne; Tjoa, Tom; Tifrea, Delia; Crews, Bridgit O; Monuki, Edwin S; Khan, Saahir; Schubl, Sebastian D; Bittencourt, Cassiana E; Detweiler, Neil; Chang, Wayne; Willis, Lynn; Khusbu, Usme; Saturno, Antonella; Rezk, Sherif A; Figueroa, Cesar; Jain, Aarti; Assis, Rafael; Felgner, Philip; Edwards, Robert; Hsieh, Lanny; Forthal, Donald; Wilson, William C; Stamos, Michael J; Huang, Susan S.
  • Gohil SK; Epidemiology and Infection Prevention Program, Irvine Health (UC Irvine Health), University of California, Irvine, USA. skgohil@hs.uci.edu.
  • Quan KA; Division of Infectious Diseases, Department of Medicine, Irvine School of Medicine, University of California, 100 Theory, Suite 120, Irvine, CA, 92617, USA. skgohil@hs.uci.edu.
  • Madey KM; Epidemiology and Infection Prevention Program, Irvine Health (UC Irvine Health), University of California, Irvine, USA.
  • King-Adelsohn S; Epidemiology and Infection Prevention Program, Irvine Health (UC Irvine Health), University of California, Irvine, USA.
  • Tjoa T; Pathology and Laboratory Medicine, UCI Health, Newport Beach, USA.
  • Tifrea D; Division of Infectious Diseases, Department of Medicine, Irvine School of Medicine, University of California, 100 Theory, Suite 120, Irvine, CA, 92617, USA.
  • Crews BO; Pathology and Laboratory Medicine, UCI Health, Newport Beach, USA.
  • Monuki ES; Pathology and Laboratory Medicine, UCI Health, Newport Beach, USA.
  • Khan S; Pathology and Laboratory Medicine, UCI Health, Newport Beach, USA.
  • Schubl SD; Division of Infectious Diseases, Keck School of Medicine, University of Southern California, Los Angeles, USA.
  • Bittencourt CE; Department of Surgery, Irvine School of Medicine, University of California, Irvine, USA.
  • Detweiler N; Pathology and Laboratory Medicine, UCI Health, Newport Beach, USA.
  • Chang W; Pathology and Laboratory Medicine, UCI Health, Newport Beach, USA.
  • Willis L; Division of Occupational and Environmental Medicine, Irvine School of Medicine, University of California, Irvine, USA.
  • Khusbu U; Epidemiology and Infection Prevention Program, Irvine Health (UC Irvine Health), University of California, Irvine, USA.
  • Saturno A; Epidemiology and Infection Prevention Program, Irvine Health (UC Irvine Health), University of California, Irvine, USA.
  • Rezk SA; Epidemiology and Infection Prevention Program, Irvine Health (UC Irvine Health), University of California, Irvine, USA.
  • Figueroa C; Pathology and Laboratory Medicine, UCI Health, Newport Beach, USA.
  • Jain A; Department of Surgery, Irvine School of Medicine, University of California, Irvine, USA.
  • Assis R; Department of Physiology and Biophysics, University of California, Irvine, USA.
  • Felgner P; Department of Physiology and Biophysics, University of California, Irvine, USA.
  • Edwards R; Department of Physiology and Biophysics, University of California, Irvine, USA.
  • Hsieh L; Pathology and Laboratory Medicine, UCI Health, Newport Beach, USA.
  • Forthal D; Division of Infectious Diseases, Department of Medicine, Irvine School of Medicine, University of California, 100 Theory, Suite 120, Irvine, CA, 92617, USA.
  • Wilson WC; Division of Infectious Diseases, Department of Medicine, Irvine School of Medicine, University of California, 100 Theory, Suite 120, Irvine, CA, 92617, USA.
  • Stamos MJ; Chief Medical Officer, UC Irvine Health, Orange, USA.
  • Huang SS; Department of Surgery, Irvine School of Medicine, University of California, Irvine, USA.
Antimicrob Resist Infect Control ; 10(1): 163, 2021 11 22.
Article in English | MEDLINE | ID: covidwho-1528697
ABSTRACT

BACKGROUND:

Early evaluations of healthcare professional (HCP) COVID-19 risk occurred during insufficient personal protective equipment and disproportionate testing, contributing to perceptions of high patient-care related HCP risk. We evaluated HCP COVID-19 seropositivity after accounting for community factors and coworker outbreaks.

METHODS:

Prior to universal masking, we conducted a single-center retrospective cohort plus cross-sectional study. All HCP (1) seen by Occupational Health for COVID-like symptoms (regardless of test result) or assigned to (2) dedicated COVID-19 units, (3) units with a COVID-19 HCP outbreak, or (4) control units from 01/01/2020 to 04/15/2020 were offered serologic testing by an FDA-authorized assay plus a research assay against 67 respiratory viruses, including 11 SARS-CoV-2 antigens. Multivariable models assessed the association of demographics, job role, comorbidities, care of a COVID-19 patient, and geocoded socioeconomic status with positive serology.

RESULTS:

Of 654 participants, 87 (13.3%) were seropositive; among these 60.8% (N = 52) had never cared for a COVID-19 patient. Being male (OR 1.79, CI 1.05-3.04, p = 0.03), working in a unit with a HCP-outbreak unit (OR 2.21, CI 1.28-3.81, p < 0.01), living in a community with low owner-occupied housing (OR = 1.63, CI = 1.00-2.64, p = 0.05), and ethnically Latino (OR 2.10, CI 1.12-3.96, p = 0.02) were positively-associated with COVID-19 seropositivity, while working in dedicated COVID-19 units was negatively-associated (OR 0.53, CI = 0.30-0.94, p = 0.03). The research assay identified 25 additional seropositive individuals (78 [12%] vs. 53 [8%], p < 0.01).

CONCLUSIONS:

Prior to universal masking, HCP COVID-19 risk was dominated by workplace and community exposures while working in a dedicated COVID-19 unit was protective, suggesting that infection prevention protocols prevent patient-to-HCP transmission. Prior to universal masking, HCP COVID-19 risk was dominated by workplace and community exposures while working in a dedicated COVID-19 unit was protective, suggesting that infection prevention protocols prevent patient-to-HCP transmission.
Subject(s)
Keywords

Full text: Available Collection: International databases Database: MEDLINE Main subject: Infection Control / Health Personnel / COVID-19 Type of study: Cohort study / Experimental Studies / Observational study / Prognostic study / Randomized controlled trials Limits: Adult / Female / Humans / Male / Middle aged Country/Region as subject: North America Language: English Journal: Antimicrob Resist Infect Control Year: 2021 Document Type: Article Affiliation country: S13756-021-01031-5

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: Infection Control / Health Personnel / COVID-19 Type of study: Cohort study / Experimental Studies / Observational study / Prognostic study / Randomized controlled trials Limits: Adult / Female / Humans / Male / Middle aged Country/Region as subject: North America Language: English Journal: Antimicrob Resist Infect Control Year: 2021 Document Type: Article Affiliation country: S13756-021-01031-5